Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by VerusSemperSorson Feb 08, 2018 11:10am

70 Views

Post# 27526630

RE:RE:Insiders bought more than they sold H1 2017 & at higher SP

My source is TD Waterhouse.

And that is correct, there were no buys or sells by insiders over the last 6 months.

I was referring to the first half (H1) of 2017 - as per my post.

There was only a bit more buying than selling. So this is not hugely bullish. But as they say there are many reasons to sell, but only one reason to buy.

-GLTA

Bullboard Posts

StockTalk | Cannabis Report: New CEO, new dispensaries, new strains